Jump to any asset
850 assets, updated daily
As of September 11, 2026, Thermo Fisher Scientific Inc. (TMO) trades at $607.50. CleaRank Financial AI rates it Buy with a fair value of $650.00, 7.0% above the current price. Wall Street's consensus target is $650.00 across 29 analysts. RSI at 37 is in neutral territory, and the price is above its 50-day average of $578.44.
Thermo Fisher Scientific Inc. (TMO)
Thermo Fisher Scientific Inc. NYSE
$607.50
4.320 (0.72%)
Latest Price
AI Analyst Consensus
72 / 100
Thermo Fisher Scientific Inc. (TMO) is currently trading at $607.50, above its 50-day and 200-day moving averages ($578.44 and $536.62), indicating positive short-to-medium term momentum. The company operates in the Diagnostics & Research industry within the Healthcare sector, a space where sector averages show a median P/E of 31.9 and revenue growth of 8.1%. Analysts maintain a 'Buy' consensus with a median price target of $650.00, suggesting a 7% upside. Recent earnings have shown consistent beats, with the latest quarter exceeding estimates by 5.6%. However, significant insider selling totaling $172.4 million contrasts with the positive analyst outlook, presenting a key risk to monitor.
TMO Price Analysis
Market Metrics
Open
$609.36
Day Range
$606.26 to $610.92
Prev Close
$603.18
Volume
23.1K
52-Week Range
$435.27 to $647.00
Market Cap
$223.02B
Peer Benchmarking
Valuation vs Sector (Healthcare)
Performance vs XLV
Sector Position Analysis
Valuation is broadly in line with sector peers (2% difference), suggesting fair market pricing relative to industry standards.
TMO Financial Performance
Revenue vs. Earnings
Annual
Quarterly
Earnings Reality Check
Analysis: In the last 5 quarters, TMO beat estimates 5 times. However, the stock fell 3 times the next day. This suggests positive news is often "priced in" or investors are selling the news.
TMO Analysis
Company's Health
4/5
12-Month Analyst Target
+7.00% Upside
Median of 29 analysts (12-month)
$650.00
AI Technical Analysis
Thermo Fisher Scientific Inc. (TMO) is trading above its 50-day and 200-day moving averages ($578.44 and $536.62), signaling an overall bullish trend. The RSI is at 36.84, indicating bearish momentum, suggesting a potential for a pullback or consolidation. MACD is positive at 7.74, supporting the current upward trend. Key support levels are implied by the moving averages, with the 50-day SMA at $578.44 and the 200-day SMA at $536.62. Volume remains significantly below average, suggesting a lack of strong conviction behind recent price action.
ProTips
- Monitor insider selling activity closely, as the recent $172.4 million in dispositions could signal a shift in management's short-term confidence.
- The stock's RSI is in bearish territory, suggesting that a pullback or consolidation phase may be imminent, despite trading above key moving averages.
- Consider position sizing carefully given the significant insider selling and the relatively modest analyst upside potential.
Key Catalysts
Bullish
Consistent Earnings Beats
Thermo Fisher Scientific Inc. (TMO) has a track record of exceeding analyst EPS estimates, most recently by 5.6% in Q3 2026, which supports ongoing investor confidence.
Source: Earnings ReportsBullish
Strong Revenue Growth
The company's revenue growth of 10.5% surpasses the sector average, indicating effective market penetration and demand for its diagnostics and research products.
Source: Company FilingsBearish
Heavy Insider Selling Signal
Insiders have sold a substantial $172.4 million worth of TMO stock, indicating potential concerns or profit-taking at current valuation levels.
Source: Insider TransactionsBearish
Bearish RSI Momentum
The current RSI of 36.84 suggests weakening momentum and a potential for a short-term price correction.
Source: Technical AnalysisMarket Outlook
Thermo Fisher Scientific Inc. (TMO) is expected to see continued growth, with analysts projecting revenue of approximately $47.9 billion for the current year, representing a 7.00% increase year-over-year. The median price target of $650.00 suggests a modest 7% upside from current levels, reflecting a base case scenario where the company maintains its market leadership and consistent earnings performance. The company's strong revenue growth, outpacing sector averages, supports this outlook.
Key Statistics
| Market Cap | 223.02B |
|---|---|
| P/E Ratio | 32.63 |
| EPS (TTM) | 18.57 |
| Dividend Yield | 0.2963% |
| 52 Week High | 647.00 |
| 52 Week Low | 435.27 |
Thermo Fisher Scientific Inc. (TMO) exhibits a P/E ratio of 32.63, which is slightly above the sector median of 31.9, indicating a modest premium valuation. The company's revenue growth of 10.5% outpaces the sector average of 8.1%, suggesting strong market positioning. The consistent earnings beats and positive revenue trajectory support the current valuation. The dividend yield is approximately 0.30%, offering a small income component.
Earnings & Growth Analysis
Thermo Fisher Scientific Inc. (TMO) has demonstrated a pattern of exceeding analyst earnings expectations. The most recent quarter, ending July 23, 2026, saw EPS of $6.03 against an estimate of $5.71, a 5.6% surprise, though the stock saw a minor decline of 0.71%. Prior quarters also showed positive surprises, including a significant 30.35% beat in March 2026. Revenue growth has been strong, with current year estimates projecting 7.00% year-over-year growth.
Key Risks
Significant insider selling, totaling $172.4 million, presents a notable risk, contrasting with the generally positive analyst sentiment. While the stock is trading above key moving averages, the bearish RSI momentum suggests potential for a near-term pullback. Competition within the Diagnostics & Research industry remains intense, requiring continuous innovation and market share defense.
Technical Indicators
| RSI (14) | 36.84 |
|---|---|
| MACD | 7.74 |
| SMA 50 | 578.44 |
| SMA 200 | 536.62 |
RSI
Bearish
SMA Cross
Bullish
Price vs SMA
Bullish
MACD
Bullish
Golden Cross in effect with the 50-day SMA ($578.44) above the 200-day SMA ($536.62), price action is firmly bullish above key moving averages.
Market Correlations
How this stock moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
S&P 500 (SPY)
+0.41
Moderate correlation
Nasdaq 100 (QQQ)
+0.29
Weak correlation
Bitcoin (BTC)
+0.20
Weak correlation
Gold (XAU)
+0.05
Weak correlation
Check Custom Correlation
Calculating correlation...
TMO Trade Plans
Specific entry, exit, and risk management levels
Select Your Trade Bias
Risk Tolerance
Conservative
2%
Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →
🟢 LONG ENTRY (click to switch)
CONSERVATIVE
$595.35
2% below current price (Pullback entry)
Lower risk, wait for pullback
AGGRESSIVE
$607.50
Buy at current price
Higher risk, immediate entry
Risk Management
STOP LOSS
$577.49
MAX LOSS
-3.0%
Volatility-Adjusted Stop Loss
Calculated based on RSI (36.8) and current market volatility
Profit Targets (Based on Conservative Entry)
TARGET 1
$625.12
+5% (Conservative)
+2.9% (Aggressive)
TARGET 2
$654.89
+10% (Conservative)
+7.8% (Aggressive)
TARGET 3
$684.65
+15% (Conservative)
+12.7% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
Calculate Your Trade
Disclaimer
This AI-generated trade plan for TMO is for educational and informational purposes only and does not constitute financial advice. The analysis is based on historical data patterns and technical indicators which may not predict future results. Stock trading involves risk of loss. Verify all data independently and consult a qualified financial advisor. Generated on September 11, 2026.Growth of $10,000
A $10,000 investment in TMO in September 2016 would be worth about $41,201 today, compared with about $35,030 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in TMO today could grow to about $28,369 by 2036 in the base case, with a bull case near $83,254 and a bear case around $9,667. Projections are statistical simulations, not guarantees.
TMO Stock Price Prediction: 2030
CleaRank's simulation projects a price near $922 for TMO by 2030 in the base case, from $608 today (1.5x over 4 years). The downside path ends near $467. These are outcomes of a Monte Carlo simulation run on TMO's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | Downside (10th pct) | Base case | Upside (90th pct) |
|---|---|---|---|
| 2027 | $480 | $674 | $948 |
| 2028 | $462 | $748 | $1,211 |
| 2029 | $461 | $831 | $1,498 |
| 2030 | $467 | $922 | $1,821 |
| 2031 | $478 | $1,023 | $2,191 |
| 2032 | $493 | $1,136 | $2,615 |
| 2033 | $512 | $1,260 | $3,103 |
| 2034 | $534 | $1,399 | $3,665 |
| 2035 | $559 | $1,553 | $4,312 |
| 2036 | $587 | $1,723 | $5,058 |
Method: 10,000 simulated price paths using TMO's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.
People Also Watch
TMO Insider Trading Analysis
Bought
None
No open-market buys
Sold
$172.4M
34 Transactions
Insiders
20
Active Traders
Avg Transaction
$5.1M
Large trades
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Dec 3, 2025 | LAGARDE MICHEL
Chief Operating Officer
|
Sell | 62.0K | $36.1M |
| Nov 2, 2021 | STEVENSON MARK P
Chief Operating Officer
|
Sell | 53.9K | $34.2M |
| Oct 1, 2018 | CASPER MARC N
Chief Executive Officer
|
Sell | 125.5K | $31.1M |
| May 10, 2021 | LAGARDE MICHEL
Officer
|
Sell | 55.8K | $26.2M |
| Feb 10, 2023 | CASPER MARC N
Chief Executive Officer
|
Sell | 40.0K | $22.9M |
| Dec 1, 2021 | STEVENSON MARK P
Chief Operating Officer
|
Sell | 26.9K | $17.0M |
| Jul 29, 2020 | CASPER MARC N
Chief Executive Officer
|
Sell | 40.0K | $16.5M |
| Aug 15, 2022 | WILLIAMSON STEPHEN
Chief Financial Officer
|
Sell | 27.3K | $16.4M |
| May 27, 2022 | LAGARDE MICHEL
Chief Operating Officer
|
Sell | 29.8K | $16.3M |
| Jul 31, 2020 | CASPER MARC N
Chief Executive Officer
|
Sell | 40.0K | $16.3M |
Page 1 of 1
Frequently Asked Questions
Is Thermo Fisher Scientific Inc. stock a buy?
Thermo Fisher Scientific Inc. (TMO) is currently rated a 'Buy' by Wall Street analysts, with a median price target of $650.00, indicating a 7% upside potential from its current price of $607.50. The company consistently beats earnings estimates and shows strong revenue growth.
What is Thermo Fisher Scientific Inc.'s stock price forecast for 2030?
Based on Monte Carlo simulations, Thermo Fisher Scientific Inc.'s (TMO) stock price is projected to be around $921.90 by 2030 in a base case scenario, with a downside projection of $466.63 and an upside projection of $1821.36.
What are the main risks for Thermo Fisher Scientific Inc. stock?
The primary risks for Thermo Fisher Scientific Inc. (TMO) include significant insider selling totaling $172.4 million and bearish momentum indicated by its RSI. Intense competition within the healthcare diagnostics sector also poses a challenge.
How has Thermo Fisher Scientific Inc. performed in recent earnings reports?
Thermo Fisher Scientific Inc. (TMO) has a history of beating earnings estimates, with the latest quarter showing a 5.6% EPS surprise. Revenue growth remains strong, projected at 7.00% for the current year.
What is Thermo Fisher Scientific Inc.'s valuation compared to its sector?
Thermo Fisher Scientific Inc. (TMO) trades at a P/E ratio of 32.63, which is slightly higher than the sector median of 31.9. However, its revenue growth of 10.5% exceeds the sector average of 8.1%.
What is the analyst consensus for Thermo Fisher Scientific Inc. stock?
The analyst consensus for Thermo Fisher Scientific Inc. (TMO) is 'Buy', supported by a Wall Street score of 72 out of 100. There are 4 'Strong Buy' ratings, 19 'Buy' ratings, and 5 'Hold' ratings among 29 analysts.
What is the current technical outlook for Thermo Fisher Scientific Inc. stock?
Thermo Fisher Scientific Inc. (TMO) is trading above its 50-day and 200-day moving averages ($578.44 and $536.62), indicating a generally positive trend. However, its RSI is in bearish territory, suggesting potential for a short-term pullback.